Chemspec Europe 2026 is the 39th International Exhibition for Fine and Specialty Chemicals, scheduled to take place on 6–7 May 2026 at the Koelnmesse Exhibition Center in Cologne. Recognized as a leading marketplace for the global fine and specialty chemicals industry, the event serves as a key platform for manufacturers, suppliers, distributors, and buyers to connect and explore business opportunities. Over two days, it is expected to host more than 400 exhibitors and over 4,000 industry professionals from 60+ countries, creating a highly focused environment for networking and sourcing. The exhibition covers a wide range of sectors, including pharmaceutical and agrochemical intermediates, APIs, custom synthesis, contract manufacturing, and specialty ingredients for coatings, cosmetics, and electronics. Alongside the exhibition, expert-led conferences and technical sessions provide insights into market trends, sustainability, regulatory developments, and innovation. Chemspec Europe 2026 plays a crucial role in enabling companies to showcase their capabilities, build strategic partnerships, and stay competitive in a rapidly evolving global chemical industry.
IOLCP stands out as a globally integrated player in the specialty chemicals segment, backed by over three decades of manufacturing excellence and innovation. Headquartered in India, IOLCP has established itself as a reliable supplier of high-quality specialty chemicals and pharmaceutical intermediates to both domestic and international markets. Its specialty chemicals portfolio includes key products such as ethyl acetate, acetic anhydride, iso butyl benzene, and acetyl chloride, catering to diverse industries like pharmaceuticals, packaging, paints, textiles, and agrochemicals. The company is particularly recognized for its large-scale production of ethyl acetate, a widely used green solvent, reflecting its strong commitment to sustainability and environmentally responsible manufacturing. With world-class manufacturing infrastructure, strong backward integration, and stringent quality standards, IOLCP delivers cost-efficient and reliable solutions to global customers. Its continuous focus on research, innovation, and sustainable growth positions it as a preferred partner for specialty chemical requirements, making its participation at Chemspec Europe 2026 highly relevant for global buyers seeking dependable and future-ready chemical solutions.
Learn moreFounded 30 years ago, IOL Chemicals and Pharmaceuticals Limited is one of the most consistent pharma companies in delivering innovation-driven solutions to market needs.

To be amongst the most admired companies in APIs, Intermediaries, and Specialty Chemicals globally.
Know More
To provide top quality products in APIs, Intermediates and Specialty Chemicals through continuous innovation and cutting-edge technology, with due regards to safety and environment.
Know More
We at IOL, believe values bring character to any organization that help leaders to guide teams for a culture of excellence through continuous improvements.
1986
» 1986
IOL Chemicals and
Pharmaceutical Limited was incorporated in 1986 with Acetic Acid Plant
1996
»
1996
Commencement of Ethyl Acetate Plant
1999
»
1999
Commencement of Acetic Anhydride Plant
2000
»
2000
Commencement of Ibuprofen Unit-1
2007
»
2007
Established Unit-1 dedicated for Ibuprofen Established Multi
fuel
captive co-generation power plant of 4MW capacity
2009
»
2009
Commencement of Iso Butyl Benezene, Mono Chloro Acetic Acid and
Acetyl Chloride Plant leading to backward integration to Ibuprofen
2017
»
2017
Conversion of Unit-2 as dedicated facility for Ibuprofen
2016
»
2016
Commencement of Unit-3 for new product launches
2015
»
2015
USFDA EIR for Ibuprofen
2013
»
2013
Received EUGMP certification
2012
»
2012
Commencement of Unit-2 for Multi product
2010
» 2010
IOL gets listed on
the
National Stock Exchange (NSE) Established Multi fuel captive co-generation power
plant
of 13MW capacity 2012
2018
» 2018
Established Unit-4
dedicated for Metformin Hydrochloride Unit-5 dedicated for Clopidogrel Bisulfate
Form II
& Fenofibrate
2019
»
2019
Established Unit-6 dedicated for Pantoprazole Sodium
2020
»
2020
Established Unit-7 dedicated for Metformin
2021
»
2021
Established Unit-8 for Multi Products
2022
» 2022
Began commercial production of Paracetamol
2023
» 2023
Recommencement of Acetic Anhydride
2025
» 2025
Commencement of Unit-11 Paracetamol